These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 35070484)
1. A retrospective review of canine benign prostatic hyperplasia with and without prostatitis. Ruetten H; Wehber M; Murphy M; Cole C; Sandhu S; Oakes S; Bjorling D; Waller K; Viviano K; Vezina C Clin Theriogenology; 2021 Dec; 13(4):360-366. PubMed ID: 35070484 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study. Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908 [TBL] [Abstract][Full Text] [Related]
3. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs. Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575 [TBL] [Abstract][Full Text] [Related]
4. The association between the serum concentration of canine prostate specific esterase (CPSE) and the size of the canine prostate. Holst BS; Holmroos E; Friling L; Hanås S; Langborg LM; Franko MA; Hansson K Theriogenology; 2017 Apr; 93():33-39. PubMed ID: 28257864 [TBL] [Abstract][Full Text] [Related]
5. Validation of a model to develop a symptom index for benign prostatic hyperplasia in dogs. Zambelli D; Cunto M; Gentilini F Reprod Domest Anim; 2012 Dec; 47 Suppl 6():229-31. PubMed ID: 23279506 [TBL] [Abstract][Full Text] [Related]
6. Changes in the Serum Prostatic Biomarkers During the Treatment of Benign Prostatic Hyperplasia with a 5alpha-reductase Inhibitor: Finasteride. Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M Top Companion Anim Med; 2020 Mar; 38():100405. PubMed ID: 32115076 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia. Pinheiro D; Machado J; Viegas C; Baptista C; Bastos E; Magalhães J; Pires MA; Cardoso L; Martins-Bessa A BMC Vet Res; 2017 Mar; 13(1):76. PubMed ID: 28335775 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention. Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554 [TBL] [Abstract][Full Text] [Related]
9. Echotexture Analysis of Prostate Parenchyma for Detection of Benign Prostatic Hyperplasia in Dogs. Khanbazi MH; Mogheiseh A; Ahrari Khafi MS; Nazifi S; Derakhshandeh N; Golchin-Rad K Top Companion Anim Med; 2021 Mar; 42():100501. PubMed ID: 33249242 [TBL] [Abstract][Full Text] [Related]
10. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate. van Vuuren SP; Heyns CF; Zarrabi AD BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551 [TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia in the dog. Cunto M; Ballotta G; Zambelli D Anim Reprod Sci; 2022 Dec; 247():107096. PubMed ID: 36279818 [TBL] [Abstract][Full Text] [Related]
12. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study. Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357 [TBL] [Abstract][Full Text] [Related]
13. Acute colonic impaction and faecaloma due to canine benign prostatic hyperplasia - Case report. Ferré-Dolcet L; Sussan B Acta Vet Hung; 2021 Apr; 69(1):9-13. PubMed ID: 33844640 [TBL] [Abstract][Full Text] [Related]
14. Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models. Sun F; Báez-Díaz C; Sánchez-Margallo FM Transl Androl Urol; 2017 Jun; 6(3):547-555. PubMed ID: 28725598 [TBL] [Abstract][Full Text] [Related]
16. Predictive Factors for Tissue Inflammation in Patients with Benign Prostatic Hyperplasia: A Clinical Prediction Study. Luo H; Liao G; Wang X; He C; Liu Y Urol Int; 2024 Aug; ():1-9. PubMed ID: 39154636 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of GDNF and FGF-1 in Canine Benign Prostatic Hyperplasia: Evidence for a Pathogenetic Role of Neural Growth Factor. Khodamoradi P; Amniattalab A; Alizadeh S J Comp Pathol; 2021 Jan; 182():43-53. PubMed ID: 33494907 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas. Yue L; Wang T; Ge Y; Ge M; Zhang C; Hou Q; Wang W; Tian H; Ren B; Du B; Zhang W Prostate; 2019 Feb; 79(3):312-319. PubMed ID: 30450670 [TBL] [Abstract][Full Text] [Related]
19. Computed Tomography of the Prostate Gland in Healthy Intact Dogs and Dogs with Benign Prostatic Hyperplasia. Pasikowska J; Hebel M; Niżański W; Nowak M Reprod Domest Anim; 2015 Oct; 50(5):776-83. PubMed ID: 26303126 [TBL] [Abstract][Full Text] [Related]
20. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH. Nickel JC; Elhilali M; Vallancien G; BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]